Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

Z Liu, M Shi, Y Ren, H Xu, S Weng, W Ning, X Ge… - Molecular Cancer, 2023 - Springer
The incidence and mortality of cancer are the major health issue worldwide. Apart from the
treatments developed to date, the unsatisfactory therapeutic effects of cancers have not …

Applications of CRISPR epigenome editors in tumor immunology and autoimmunity

B Yahsi, F Palaz, P Dincer - ACS Synthetic Biology, 2024 - ACS Publications
Over the past decade, CRISPR-Cas systems have become indispensable tools for genetic
engineering and have been used in clinical trials for various diseases. Beyond genome …

Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9

LO Afolabi, AO Adeshakin, MM Sani, J Bi, X Wan - Immunology, 2019 - Wiley Online Library
Natural killer cells are potent cytotoxic lymphocytes specialized in recognizing and
eliminating transformed cells, and in orchestrating adaptive anti‐tumour immunity. However …

Innovative strategies of reprogramming immune system cells by targeting CRISPR/Cas9-based genome-editing tools: a new era of cancer management

KS Allemailem, MA Alsahli, A Almatroudi… - International Journal …, 2023 - Taylor & Francis
The recent developments in the study of clustered regularly interspaced short palindromic
repeats/associated protein 9 (CRISPR/Cas9) system have revolutionized the art of genome …

Expression of circular RNA CDR1‑AS in colon cancer cells increases cell surface PD‑L1 protein levels

E Tanaka, Y Miyakawa, T Kishikawa… - Oncology …, 2019 - spandidos-publications.com
The expression of CDR1‑AS, a representative circular RNA, is closely linked with poor
prognosis in gastrointestinal cancers, such as colon, liver, and pancreatic cancers. Although …

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy

LO Afolabi, MO Afolabi, MM Sani… - Clinical & …, 2021 - Wiley Online Library
The discovery of clustered regularly interspaced short palindromic repeats and CRISPR‐
associated protein 9 (CRISPR‐Cas9) technology has brought advances in the genetic …

[HTML][HTML] Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy

S Douka, V Papamoschou, M Raimo, E Mastrobattista… - Pharmaceutics, 2024 - mdpi.com
Natural killer (NK) cells have recently gained popularity as an alternative for cancer
immunotherapy. Adoptive cell transfer employing NK cells offers a safer therapeutic option …

Engineering metabolism of chimeric antigen receptor (CAR) cells for developing efficient immunotherapies

JL Mangal, JL Handlos, A Esrafili, S Inamdar… - Cancers, 2021 - mdpi.com
Simple Summary This review paper here describes the recent progress that has been made
in chimeric antigen receptor (CAR)-based therapies for treatment of tumors and the role of …

Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design

S Shankar, A Sreekumar, D Prasad, AV Das… - Cancer cell …, 2018 - Springer
Background Gene knockout technologies involving programmable nucleases have been
used to create knockouts in several applications. Gene editing using Zinc-finger nucleases …

Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR‐NK Cell Engineering

Z Zhou, Y Chen, Y Ba, H Xu, A Zuo, S Liu… - Cell …, 2024 - Wiley Online Library
The recent advancements in cancer immunotherapy have spotlighted the potential of natural
killer (NK) cells, particularly chimeric antigen receptor (CAR)–transduced NK cells. These …